Advertisement

Clinical Usefulness and Optimal Harvesting of Peripheral Blood Stem Cells Mobilized by High Dose Cyclophosphamide and Recombinant Human GM-CSF

  • A. M. Gianni
  • M. Bregni
  • S. Siena
  • C. Tarella
  • D. Caracciolo
  • F. Ravagnani
  • A. C. Stern

Abstract

The existence of normal hematopoietic stem cells in the peripheral blood of mammals has been known for a quarter of a century [1]; however, they were first used to reconstitute the bone marrow of patients after myeloablative chemoradiotherapy only 4–5 years ago [2–6]. After obtaining proof that circulating progenitors are capable of complete and long-lasting hematopoietic reconstitution, clinicians have increasingly employed them as an alternative to bone marrow-derived stem cells. By the end of 1989, over 200 autotransplants of peripheral blood stem cells had been reported or published.

Keywords

Peripheral Blood Stem Cell Bone Marrow Involvement Peripheral Blood Stem Cell Transplant Optimal Harvesting Peripheral Blood Progenitor Cell 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Epstein RB, Graham TC, Buckner CD, et al. (1966) Allogeneic bone marrow transplan-tation engraftment by cross circulation in lethally irradiated dogs. Blood 28: 692–707PubMedGoogle Scholar
  2. 2.
    Juttner CA, To LB, Haylock DN, et al. (1985) Circulating autologous stem cell collected in very early remission from acute non-lymphoblastic leukaemia produce prompt but incomplete hematopoietic reconstitution after high dose melphalan or supralethal chemoradiotherapy. Br J Hematol 61: 739–745CrossRefGoogle Scholar
  3. 3.
    Reifers J, Bernard P, David B, et al. (1986) Successful autologous transplantation with peripheral blood hematopoietic cells in a patient with acute leukemia. Exp Hematol 14: 312–315Google Scholar
  4. 4.
    Korbling M, Dorken B, Ho AD, et al. (1986) Autologous transplantation of blood- derived hematopoietic stem cells after myeloablative therapy in a patient with Burkitt’s lymphoma. Blood 67: 529–532PubMedGoogle Scholar
  5. 5.
    Kessinger A, Armitage JO, Landmark JD, Weisenburger DD (1986) Reconstitution of human hematopoietic function with autologous cryopreserved ciruculating stem cells. Exp Hematol 14: 192–196PubMedGoogle Scholar
  6. 6.
    Castaigne S, Calvo F, Douay L, et al. (1986) Successful hematopoietic reconstitution using autologous peripheral blood mononucleated cells in a patient with acute promye¬locyte leukaemia. Br J Hematol 63: 210–211CrossRefGoogle Scholar
  7. 7.
    Storb R (1989) Bone marrow transplantation. In: De Vita VT, Hellman S, Rosenberg SA (eds) Cancer. Principles and practice of oncology, chap 66, 3rd edn. Lippincott, Philadelphia, pp 2474–2489Google Scholar
  8. 8.
    To LB, Dyson PG, Juttner CA (1986) Cell-dose effect in circulating stem-cell autografting. Lancet ii: 404–405CrossRefGoogle Scholar
  9. 9.
    Gianni AM, Siena S, Bregni M et al. (1989) Granulocyte-macrophage colony-stimulating factor to harvest circulating hematopoietic stem cells for autotransplantation. Lancet ii: 580–585CrossRefGoogle Scholar
  10. 10.
    Gianni AM, Bregni M, Siena S, et al. (1989) Rapid and complete hematopoietic reconstitution following combined transplantation of autologous blood and bone marrow cells. A changing role for high dose chemoradiotherapy? Hematol Oncol 7: 139–148PubMedCrossRefGoogle Scholar
  11. 11.
    Socinski MA, Cannistra SA, Elias A, et al. (1988) Granulocyte-macrophage colony stimulating factor expands the circulating hematopoietic progenitor cell compartment in man. Lancet i: 1194–1198CrossRefGoogle Scholar
  12. 12.
    Gianni AM, Tarella C, Siena S, et al. (1990) Durable and complete hematopoietic reconstitution after autografting of rhGM-CSF exposed peripheral blood progenitor cells. Bone Marrow Transplant 6: 143–145PubMedGoogle Scholar
  13. 13.
    Juttner CA, To LB, Haylock DN, et al. (1989) Autologous blood stem cell transplan¬tation. Transplant Proc 21: 2929–2931PubMedGoogle Scholar
  14. 14.
    Douay L, Gorin NC, Lemarie E, et al. (1986) Recovery of CFU-GM in cryopreserved marrow and in vivo evaluation after autologous bone marrow transplantation are predictive of engraftment. Exp Hematol 14: 358–365PubMedGoogle Scholar
  15. 15.
    Klimo P, Connors JM (1985) MACOP-B chemotherapy for the treatment of diffuse large-cell lymphoma. Ann Intern Med 102: 596–602PubMedGoogle Scholar
  16. 16.
    To LB, Haylock DN, Thorp D, et al. (1989) The optimization of collection of peripheral blood stem cells for autotransplantation in acute myeloid leukaemia. Bone Marrow Transplant 4: 41–47PubMedGoogle Scholar
  17. 17.
    Siena S, Bregni M, Brando B, et al. (1989) Circulation of CD34+ hematopoietic stem cells in the peripheral blood of high-dose cyclophosphamide-treated patients: enhancement by intravenous recombinant human granulocyte-macrophage colony-stimulating factor. Blood 74: 1905–1914PubMedGoogle Scholar
  18. 18.
    Siena S, Bregin N, Branto B, et al. (1991) Flow cytometry for clinical estimation of circulating hematopoietic progenitors for autologous transplantation in cancer patients. Blood 77: 400–409PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1993

Authors and Affiliations

  • A. M. Gianni
    • 1
  • M. Bregni
    • 1
  • S. Siena
    • 1
  • C. Tarella
    • 2
  • D. Caracciolo
    • 3
  • F. Ravagnani
    • 4
  • A. C. Stern
    • 5
  1. 1.Istituto Nazionale Tumori per lo Studio e la Cura dei TumoriMilanItaly
  2. 2.Division of ImmunohaematologyIstituto Nazionale per lo Studio e la Cura dei TumoriMilanItaly
  3. 3.Istituto di Scienze MedicheUniversity of MilanMilanItaly
  4. 4.Cattedra di EmatologiaUniversità di TorinoTurinItaly
  5. 5.Sandoz Clinical ResearchBaselSwitzerland

Personalised recommendations